Tenet Healthcare Corp
XMUN:THC1

Watchlist Manager
Tenet Healthcare Corp Logo
Tenet Healthcare Corp
XMUN:THC1
Watchlist
Price: 226 EUR Market Closed
Market Cap: €13.8B

Tenet Healthcare Corp
Investor Relations

Tenet Healthcare runs hospitals, outpatient surgery centers, and other medical facilities in the United States. It treats patients who need everything from emergency care and inpatient hospital stays to scheduled procedures, diagnostics, and follow-up care. Its main customers are patients, doctors, employers, and health insurers that pay for covered medical services. The company makes money mainly by billing for care delivered through its hospitals and outpatient network. That includes hospital admissions, surgeries, imaging, lab work, and other services tied to each patient visit. Tenet also owns a large ambulatory surgery business, which focuses on procedures that do not require an overnight hospital stay and usually cost less than traditional inpatient care. Tenet’s role in healthcare is part provider, part local infrastructure owner. It holds the facilities, equipment, staff, and systems needed to deliver care directly, rather than just referring patients elsewhere. That makes its business different from a pure software or drug company: its earnings depend on how many patients use its facilities, what kinds of procedures they need, and how well it manages a complex, highly regulated service business.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Jul 24, 2026
AI Summary
Q2 2026

Strong quarter: Tenet reported second quarter net operating revenues of $5.6 billion and adjusted EBITDA of $1.304 billion, with adjusted diluted EPS up 52% to $6.12.

Guidance raised: Management increased 2026 revenue, adjusted EBITDA, and cash flow guidance, saying the lift is driven by core business strength, expense discipline, and continued growth into the second half.

Exchange headwind: Exchange revenues fell 17% year over year and exchange admissions were down about 13.5%, but management said the trend was broadly in line with expectations and was offset by cost actions and growth elsewhere.

USPI strength: The ambulatory business posted $542 million of adjusted EBITDA, up 9% year over year, helped by 5% same-facility revenue growth and 10% same-store total joint replacement volume growth.

Hospital outperformance: Hospital adjusted EBITDA rose 22% to $762 million, supported by stronger volumes, expense management, higher acuity, and $92 million of favorable supplemental Medicaid revenue.

Capital returns: Tenet repurchased 7 million shares for $1.36 billion in the first half and authorized a $2 billion increase to the buyback program, signaling confidence in free cash flow generation.

Key Financials
Net operating revenues
$5.6 billion
Adjusted EBITDA
$1.304 billion
Adjusted EBITDA margin
23.2%
Adjusted diluted EPS
$6.12
USPI adjusted EBITDA
$542 million
USPI adjusted EBITDA margin
39%
USPI same-facility revenues
5%
USPI net revenue per case
6.3%
USPI same-facility case volumes
down 1.2%
Hospital adjusted EBITDA
$762 million
Hospital adjusted EBITDA margin
18%
Same-hospital inpatient adjusted admissions
2.6%
Revenue per adjusted admission
3.3%
Exchange revenues
down 17%
Exchange admissions
down about 13.5%
Adjusted free cash flow
$444 million
Adjusted free cash flow year to date
$1.422 billion
Cash on hand
$2.17 billion
Share repurchases
$1.36 billion
Shares repurchased
7 million
Second quarter share repurchases
5.7 million
Leverage ratio
2.33x EBITDA
Leverage ratio less NCI
2.9x EBITDA
Supplemental Medicaid revenue
$92 million
M&A spend
more than $300 million
Earnings Call Recording
Other Earnings Calls

Management

Dr. Saumya Sutaria M.D.
Chairman & CEO
No Bio Available
Ms. Paola M. Arbour
Executive VP & Chief Information Officer
No Bio Available
Mr. Thomas W. Arnst
EVP, Chief Administrative Officer, Chief Risk Officer, General Counsel & Corporate Secretary
No Bio Available
Ms. Lisa Y. Foo
Executive Vice President of Commercial Operations
No Bio Available
Mr. Sun K. Park
Executive VP & CFO
No Bio Available
Mr. William McDowell III
Vice President of Investor Relations
No Bio Available
Ms. Jana Durfee
Senior VP & Chief Compliance Officer
No Bio Available
Mr. Michael T. Maloney
Executive Vice President of Corporate Development
No Bio Available
Mr. Clint Hailey
Chief Managed Care Officer & Senior VP
No Bio Available
Ms. Liz Johnson
Chief Applied Clinical Informatics Officer
No Bio Available

Contacts

Address
TEXAS
Dallas
14201 Dallas Parkway
Contacts
+14698932200.0
www.tenethealth.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett